November 5, 2013
Mauna Kea Technologies (Paris:MKEA) (NYSE Euronext: MKEA, FR0010609263) announced today that Joseph C. Liao MD, associate professor of urology, Stanford University, has successfully used endomicroscopy with Cellvizio for the first time in eight patients treated with robotic assisted radical prostatectomy (RARP) procedures. Results were presented in a poster presentation at the 2013 World Congress of [...]
JPT and Immudex Announce Partnership Agreement
November 5, 2013
COPENHAGEN & BERLIN -- Immudex and JPT Peptide Technologies today announced a partnership agreement on the co-distribution and co-promotion of their existing immunological product lines. The goal of this partnership is to synergistically combine JPT's innovative peptide-based core technologies and existing products with Immudex's sophisticated Dextramer products for MHC multimer assays, in order to provide [...]
ModiQuest Research and Dako to Expand Antibody Generation Collaboration
November 5, 2013
Oss, The Netherlands: ModiQuest Research BV, the Dutch antibody generation services company, today announced that it has expanded its research collaboration with Dako – an Agilent Technologies company. After the successful generation of monoclonal antibodies by ModiQuest against a proprietary target selected by Dako earlier this year, both parties have extended their collaboration with three [...]
King Willem-Alexander of the Netherlands opens the new headquarters of Applikon Biotechnology
November 5, 2013
On Wednesday December 4th the new headquarters of Applikon Biotechnology in Delft, the Netherlands will be opened by His Majesty King Willem-Alexander of the Netherlands. The grand opening will be attended by (inter)national customers, business relations,(inter)national officials, scientific relations and the entire team of the Applikon Biotechnology in the Netherlands. The new production facility has [...]
November 4, 2013
MADISON, WIS. — Cellular Dynamics International (CDI; Nasdaq:ICEL), announced today that the company has received the Notice of Grant Award (NGA) from the California Institute of Regenerative Medicine (CIRM) to create a human induced pluripotent stem cell (iPSC) biobank from 3,000 individuals. Receipt of the NGA signifies the entry into a definitive agreement with CIRM [...]
BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management
November 4, 2013
Franklin Lakes, NJ – BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved Morphine Sulfate Injection, USP to be offered in the BD Simplist line of ready-to-administer prefilled injectables in the most common [...]
Endress+Hauser establishes Saudi Arabian sales center
November 4, 2013
Measurement engineering specialist intensifies its presence in the Middle East in a joint venture with the Abudawood Group After a 10-year collaboration with Saudi Arabian sales company Anasia (Abudawood Group), measurement engineering and automation specialist Endress+Hauser will establish a joint venture to seal the partnership and intensify the local market presence. The new Endress+Hauser sales [...]
New Collaboration Aims to Detect More TB Cases in Developing Countries
November 4, 2013
Franklin Lakes, NJ and Paris, France – BD (Becton, Dickinson and Company), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics) today announced a feasibility project that will evaluate the potential use of a low-cost, image-based TB screening platform that is currently in development. This platform provides ease-of-use and semi-quantitative automated [...]
November 4, 2013
HOLLISTON, Mass.-- Harvard Bioscience, Inc. (Nasdaq:HBIO) became a pure-play global developer, manufacturer and marketer of a broad range of tools to advance life science research on November 1, 2013. This development resulted as the previously announced spin-off of its former wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, or HART, was completed as [...]
Jeffrey A. Duchemin Appointed to Additional Roles of President and Director of Harvard Bioscience
November 4, 2013
HOLLISTON, Mass. -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that its Chief Executive Officer, Jeffrey A. Duchemin, has been appointed by the Board of Directors to the additional positions of President and Director, effective immediately. He [...]
